Skip to main content
. Author manuscript; available in PMC: 2021 May 6.
Published in final edited form as: Kidney Int. 2020 Jun 14;98(5):1308–1322. doi: 10.1016/j.kint.2020.05.029

Table 2.

Trans-ethnic meta-analysis of candidate SNPs.

CHR SNP BP Effect allele P_value OR (95% CI) P_heterogeneity I2 Model
19 rs56117924 36,334,182 A 2.73E-07 1.76 (1.42-2.18) 7.51E-02 45.66 Random-effect
19 rs2073901 36,334,485 A 1.03E-20 2.04 (1.76-2.38) 4.09E-01 2.04 Fixed-effect
19 rs412175 36,342,103 C 6.21E-05 1.52 (1.24-1.87) 1.58E-02 55.80 Random-effect
19 rs2285450 36,342,267 A 6.71E-28 1.88 (1.68-2.11) 1.58E-01 33.85 Fixed-effect
19 rs404299 36,349,752 A 8.64E-04 1.56 (1.20-2.03) 1.21E-04 72.92 Random-effect
9 rs4979462 117,567,013 T 5.40E-11 1.33 (1.22-1.44) 5.16E-01 0.00 Fixed-effect
9 rs6478109 117,568,766 A 7.86E-04 0.78 (0.68-0.90) 7.01E-02 43.21 Random-effect
18 rs8086340 60,006,978 C 4.58E-02 0.88 (0.77-1.00) 3.28E-02 50.57 Random-effect
18 rs34213471 60,008,436 A 5.61E-02 1.22 (0.99-1.50) 9.63E-02 39.23 Random-effect

SNP: Single nucleotide polymorphism. BP: Physical position according to Hg19. CHR: Chromosome.

OR: Odds ratio. 95% CI: 95% confidence interval. P heterogeneity: P-value of Cochran Q test for heterogeneity. I2: Percentage of total variation across studies due to heterogeneity. Model: Meta-analysis method used. Fixed-effect: Inverse-variance method based on a fixed-effects model. Random-effect: Inverse-variance method based on a random-effects model